SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008508
Filing Date
2020-05-13
Accepted
2020-05-13 16:20:00
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 418397
2 ex10-7.htm EX-10.7 209709
3 ex31-1.htm EX-31.1 10822
4 ex31-2.htm EX-31.2 11922
5 ex32-1.htm EX-32.1 9427
  Complete submission text file 0001493152-20-008508.txt   3064457

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cocp-20200331.xml EX-101.INS 413209
7 XBRL SCHEMA FILE cocp-20200331.xsd EX-101.SCH 43468
8 XBRL CALCULATION FILE cocp-20200331_cal.xml EX-101.CAL 48174
9 XBRL DEFINITION FILE cocp-20200331_def.xml EX-101.DEF 140599
10 XBRL LABEL FILE cocp-20200331_lab.xml EX-101.LAB 295574
11 XBRL PRESENTATION FILE cocp-20200331_pre.xml EX-101.PRE 218367
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 20873421
SIC: 2834 Pharmaceutical Preparations